Review of the DoD GEIS influenza programs

By

Methodological Challenges in Biomedical HIV Prevention Trials

By

"This IOM committee was formed at the request of the Bill & Melinda Gates Foundation and charged with addressing methodological challenges in late-stage nonvaccine biomedical HIV prevention trials...

Design considerations for evaluating the impact of PEPFAR

By

Global climate change and extreme weather events

By

Long before the germ theory of disease was described, late in the nineteenth century, humans knew that climatic conditions influence the appearance and spread of epidemic diseases. Ancient notions...

Microbial evolution and co adaptation

By

"Dr. Joshua Lederberg - scientist, Nobel laureate, visionary thinker, and friend of the Forum on Microbial Threats - died on February 2, 2008. It was in his honor that the Institute of Medicine's F...

Live Variola Virus: Considerations for Continuing Research

By Ann M. Arvin

Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases

By Institute Of Medicine U.S. . Committee On Achieving Sustainable Global Capacity For Surveillance And Response To Emerging Diseases Of Zoonotic Origin

The U.S. commitment to global health

By Institute Of Medicine U.S. . Committee On The U.S. Commitment To Global Health.

Infectious disease movement in a borderless world

By David A. Relman

The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions: Workshop Summary

By Eileen R. Choffnes, Alison Mack, David A. Relman

"In March and early April 2009, a new, swine-origin 2009-H1N1 influenza A virus emerged in Mexico and the United States. During the first few weeks of surveillance, the virus spread by human-to-hum...